(1)
Funda Şimşek; The Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases*; Gökmen Zararsız; Faruk Karakeçili; Sami Kınıklı; Hüseyin Bilgin; Nesrin Türker; Gülden Ersöz; Ali Asan 0; Bilgehan Aygen. Real-World Efficacy, Safety, and Clinical Outcomes of Ombitasvir Paritaprevir Ritonavir ± Dasabuvir ± Ribavirin Combination Therapy in Patients With Hepatitis C Virus Genotype 1 or 4 Infection: The Turkey Experience Experience. Turkish Journal of Gastroenterology 2020, 31, 305-317.